Letter: Calendar Era or Antiviral Choice–What Explains the Survival Benefit of Tenofovir Disoproxil Fumarate After Hepatocellular Carcinoma Resection? Authors' Reply
Jaehong Jeong, Hye Won Lee. Letter: Calendar Era or Antiviral Choice–What Explains the Survival Benefit of Tenofovir Disoproxil Fumarate After Hepatocellular Carcinoma Resection? Authors' Reply. // Alimentary Pharmacology and Therapeutics. – 2026. – DOI: 10.1111/apt.70953. – URL: https://onlinelibrary.wiley.com/doi/10.1111/apt.70953?af=R
Jaehong Jeong & Hye Won Lee (2026). Letter: Calendar Era or Antiviral Choice–What Explains the Survival Benefit of Tenofovir Disoproxil Fumarate After Hepatocellular Carcinoma Resection? Authors' Reply. Alimentary Pharmacology and Therapeutics. https://doi.org/10.1111/apt.70953
Jaehong Jeong and Hye Won Lee. “Letter: Calendar Era or Antiviral Choice–What Explains the Survival Benefit of Tenofovir Disoproxil Fumarate After Hepatocellular Carcinoma Resection? Authors' Reply.” Alimentary Pharmacology and Therapeutics, 2026. doi:10.1111/apt.70953.
@article{Jeong2026,
title = {Letter: Calendar Era or Antiviral Choice–What Explains the Survival Benefit of Tenofovir Disoproxil Fumarate After Hepatocellular Carcinoma Resection? Authors' Reply},
author = {Jeong, Jaehong and Lee, Hye Won},
journal = {Alimentary Pharmacology and Therapeutics},
year = {2026},
doi = {10.1111/apt.70953},
url = {https://onlinelibrary.wiley.com/doi/10.1111/apt.70953?af=R}
}